Tilray Brands, Inc. (TLRY) (Q3FY23)
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.
The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products.
The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P’tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers.
Tilray announced its acquisition of Hexo, a deal valued at ~$56mn. Prior to the announcement, Hexo had a market capitalization of over $70mn.
The acquisition is an all-stock transaction. Tilray’s acquisition of Hexo will bring in valuable operations and distribution assets that are considered “low-cost” by Tilray. This acquisition is expected to increase Tilray’s revenue and expand its market share in Canada to ~13%.
The stock price showed a downward trend in past 3-months period. It declined by 33.99% during the period. The stock price declined by 53.99% in past 1-year. The stock has a 52-week high of $5.12 and its 52-week low is $1.56.
This report is useful for M&A, business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.
– Enterprise Value
– CrispIdea Forecast
– CrispIdea Segment Forecast
– Economic Value Added Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum
Actual & Historical Performance
– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Segment Performance
– Key Developments
– M&A Deals
– Price Performance
Stock Price Performance
No of Pages: 33
To download the previous quarter’s equity report CLICK HERE
Follow our LinkedIn page for more updates